Relmada Therapeutics Provides Corporate Update and Reports Third Quarter 2023 Financial Results

December 15, 2023

https://www.prnewswire.com/news-releases/relmada-therapeutics-provides-corporate-update-and-reports-third-quarter-2023-financial-results-301982239.html

CORAL GABLES, Fla., Nov. 8, 2023 /PRNewswire/ — Relmada Therapeutics, Inc. (Nasdaq: RLMD), a late-stage biotechnology company addressing diseases of the central nervous system (CNS), today provided a corporate update and announced preliminary and unaudited financial results for the third quarter ended September 30, 2023. The Company will host a conference call today, Wednesday, November 8, at 4:30 PM Eastern Time/1:30 PM Pacific Time.

Read more at prnewswire.com

Related news for (RLMD)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.